Astrazeneca ADR Aktie
Deine Einschätzung
Astrazeneca ADR Aktie
Was spricht für und gegen Astrazeneca ADR in den nächsten Jahren?
Pro
Kontra
Rendite von Astrazeneca ADR im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Astrazeneca ADR | - | - | - | - | - | - | - |
| GSK plc ADR | -2,00 % | -3,85 % | 12,11 % | 37,36 % | 19,62 % | 52,44 % | 40,85 % |
| Bayer AG ADR | -3,77 % | -6,67 % | -9,26 % | 78,18 % | 11,36 % | -31,94 % | -24,62 % |
| UCB S.A. | -1,28 % | -7,89 % | -4,51 % | 36,22 % | 5,27 % | 209,36 % | 199,14 % |
Kommentare
News
As Investors Flee U.S. Equities, This Global ETF Is Outperforming
Since the start of the year, investors have been vacating U.S. stocks and exchange-traded funds (ETFs) in a broad-based, risk-off strategy that has benefited safe-haven assets like gold and silver
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound
Since going public in mid-2024, shares of healthcare and life science services company Tempus AI (NASDAQ: TEM) have gone on a wild rollercoaster ride. The firm’s initial public offering price
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable


